Fluocinolone Acetonide
NDC 0713-0222
Product Information
Fluocinolone Acetonide is a ANDA-approved product labeled by Cosette Pharmaceuticals, Inc.. This medication is used to treat a variety of skin conditions (e. It is supplied as a product. This product entry covers the primary NDC 0713-0222 and 2 associated package configurations. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Labeler & Regulatory Data
Marketing Timeline
Code Structure Chart
Product Details
What is NDC 0713-0222?
What are the uses of this product?
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- FLUOCINOLONE ACETONIDE (UNII: 0CD5FD6S2M)
- FLUOCINOLONE ACETONIDE (UNII: 0CD5FD6S2M) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- MINERAL OIL (UNII: T5L8T28FGP)
- LANOLIN ALCOHOLS (UNII: 884C3FA9HE)
- ISOPROPYL PALMITATE (UNII: 8CRQ2TH63M)
- PROPYLENE GLYCOL STEARATE (UNII: MZM1I680W0)
- CETYL ALCOHOL (UNII: 936JST6JCN)
- SORBITAN MONOSTEARATE (UNII: NVZ4I0H58X)
- POLYSORBATE 60 (UNII: CAL22UVI4M)
- SORBIC ACID (UNII: X045WJ989B)
- POLYOXYL 40 STEARATE (UNII: 13A4J4NH9I)
- WATER (UNII: 059QF0KO0R)
- PROPYLENE GLYCOL (UNII: 6DC9Q167V3)
- PROPYLPARABEN (UNII: Z8IX2SC1OH)
- METHYLPARABEN (UNII: A2I8C7HI9T)
What is the NDC to RxNorm Crosswalk for this product?
- RxCUI: 1191256 - fluocinolone acetonide 0.025 % Topical Ointment
- RxCUI: 1191256 - fluocinolone acetonide 0.00025 MG/MG Topical Ointment
- RxCUI: 1191302 - fluocinolone acetonide 0.01 % Topical Cream
- RxCUI: 1191302 - fluocinolone acetonide 0.1 MG/ML Topical Cream
- RxCUI: 1191315 - fluocinolone acetonide 0.025 % Topical Cream
* Please review the full disclaimer at the bottom of this page.